MyAverix Finance
US · Healthcare
Evommune, Inc. (EVMN)
Biotechnology
Evommune, Inc. (EVMN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EVMN
Evommune, Inc. (EVMN) — FAQ
What is EVMN's P/E ratio?
The price-to-earnings (P/E) ratio for Evommune, Inc. (EVMN) is 18.00 (data as of 2026-03-24).
Does Evommune, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Evommune, Inc. (EVMN). Check the MyAverix Finance app for the latest dividend data.
What sector is Evommune, Inc. in?
Evommune, Inc. (EVMN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is EVMN listed on?
EVMN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.